therapy selection for patients with newly diagnosed mrcc
Published 5 years ago • 13 plays • Length 4:05Download video MP4
Download video MP3
Similar videos
-
7:55
choosing upfront therapy for mrcc
-
7:36
mrcc patient selection for ipilimumab/nivolumab
-
1:22
dr. joseph on factors influencing frontline therapy selection in mrcc
-
5:06
treatment goals in newly diagnosed mrcc
-
4:38
considerations when treating newly diagnosed mrcc
-
7:04
sunitinib 4/2 vs 2/1 schedule for patients with mrcc
-
1:25
dr. sznol on patient selection for combination therapy in mrcc
-
42:06
understanding tinnitus as a network problem | professor grant searchfield | ttm ep_5
-
1:50
dr. mauro on selecting therapies for patients with cml
-
5:02
new therapy options in newly diagnosed mrcc
-
4:26
treating patients with mrcc beyond second-line
-
10:38
considerations for using adjuvant therapy in mrcc
-
2:42
therapeutic options in newly diagnosed mrcc
-
5:10
therapeutic sequencing in mrcc
-
5:11
selecting immunotherapy versus vegf tki for mrcc
-
1:06
dr. lee on treatment options in mrcc
-
8:40
favorable-risk mrcc: choosing appropriate frontline therapy
-
10:40
treating the newly diagnosed patient with chronic myeloid leukemia
-
4:47
imdc criteria and targeted therapy in mrcc